GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $57,088,000 | +3.2% | 1,310,449 | +4.5% | 0.13% | +5.0% |
Q4 2021 | $55,310,000 | +24.6% | 1,254,176 | +8.0% | 0.12% | +1.7% |
Q3 2021 | $44,383,000 | +1.0% | 1,161,256 | +5.3% | 0.12% | -6.3% |
Q2 2021 | $43,957,000 | +34.9% | 1,102,971 | +20.8% | 0.13% | +23.3% |
Q1 2021 | $32,575,000 | +8.4% | 913,255 | +11.9% | 0.10% | -17.6% |
Q4 2020 | $30,042,000 | +1.5% | 816,271 | +3.9% | 0.12% | -12.6% |
Q3 2020 | $29,590,000 | -3.6% | 785,693 | +4.4% | 0.14% | -14.4% |
Q2 2020 | $30,686,000 | +20.1% | 752,730 | +11.7% | 0.17% | +0.6% |
Q1 2020 | $25,556,000 | -7.8% | 673,886 | +14.2% | 0.17% | +1.2% |
Q4 2019 | $27,716,000 | +13.3% | 590,097 | +2.9% | 0.16% | +23.3% |
Q3 2019 | $24,471,000 | -2.3% | 573,490 | -8.4% | 0.13% | -10.7% |
Q2 2019 | $25,040,000 | +1.0% | 626,087 | +5.5% | 0.15% | -10.2% |
Q1 2019 | $24,803,000 | +19.4% | 593,389 | +9.2% | 0.17% | +4.4% |
Q4 2018 | $20,767,000 | -0.5% | 543,564 | +4.6% | 0.16% | +6.0% |
Q3 2018 | $20,861,000 | -16.2% | 519,493 | -15.9% | 0.15% | -23.1% |
Q2 2018 | $24,884,000 | +18.9% | 617,941 | +15.6% | 0.20% | +11.4% |
Q1 2018 | $20,923,000 | +118.0% | 534,756 | +97.4% | 0.18% | +121.5% |
Q4 2017 | $9,598,000 | -48.8% | 270,945 | -41.3% | 0.08% | -50.6% |
Q3 2017 | $18,752,000 | -25.7% | 461,731 | -21.1% | 0.16% | -29.2% |
Q2 2017 | $25,252,000 | +17.0% | 585,558 | +14.3% | 0.23% | +9.2% |
Q1 2017 | $21,588,000 | +22.9% | 512,417 | +12.5% | 0.21% | +8.4% |
Q4 2016 | $17,571,000 | -14.1% | 455,678 | -4.0% | 0.19% | -19.4% |
Q3 2016 | $20,451,000 | +4.1% | 474,505 | +4.6% | 0.24% | -4.8% |
Q2 2016 | $19,646,000 | -8.0% | 453,467 | -13.9% | 0.25% | +255.7% |
Q1 2016 | $21,360,000 | +25.7% | 526,970 | +25.0% | 0.07% | -65.3% |
Q4 2015 | $16,989,000 | -13.4% | 421,705 | -17.4% | 0.20% | -22.3% |
Q3 2015 | $19,617,000 | +3.8% | 510,619 | +12.5% | 0.26% | -14.2% |
Q2 2015 | $18,905,000 | +44.1% | 453,905 | +59.7% | 0.30% | +55.4% |
Q1 2015 | $13,118,000 | +14.2% | 284,260 | +5.7% | 0.20% | +10.8% |
Q4 2014 | $11,491,000 | -6.4% | 269,030 | +0.8% | 0.18% | -15.0% |
Q3 2014 | $12,273,000 | +13.4% | 266,968 | +31.9% | 0.21% | +10.1% |
Q2 2014 | $10,825,000 | +9.5% | 202,417 | +9.4% | 0.19% | -2.6% |
Q1 2014 | $9,886,000 | +1.6% | 185,019 | +1.5% | 0.19% | -3.5% |
Q4 2013 | $9,729,000 | +23.7% | 182,226 | +16.3% | 0.20% | +1.5% |
Q3 2013 | $7,863,000 | -20.0% | 156,719 | -20.3% | 0.20% | -26.2% |
Q2 2013 | $9,827,000 | – | 196,664 | – | 0.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |